In vitro combination characterization of the new anticancer plant drug β-elemene with taxanes against human lung carcinoma

Jinshun Zhao, Qingdi Quentin Li, Baobo Zou, Gangduo Wang, Xiping Li, Jee Eun Kim, Christopher F. Cuff, Lan Huang, Eddie Reed, Kevin Gardner

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

β-elemene has recently raised interest in P.R. China as a novel antitumor plant drug isolated from the Chinese medicinal herb Zedoary. To explore potentially useful combinations of β-elemene with taxanes in the clinic, we characterized the effects of β-elemene combined with taxanes in human lung cancer cells using a median effect analysis, micronucleus assay, apoptotic detection, and determination of gene expression in the signaling pathways of apoptosis. The synergistic analysis indicated that the interactions of β-elemene with paclitaxel or docetaxel ranged from slight synergism to synergism. Combinations of β-elemene with docetaxel induced much stronger synergistic interactions in p53 mutant H23 cells and p53 null H358 cells than in p53 wild-type H460 and A549 cells. Similar synergistic interactions were observed by micronucleus assay, apoptotic detection, and determination of apoptotic gene expression. Our findings indicate that the synergistic effects achieved with combinations of β-elemene and taxanes are related to the augmented cytotoxic efficacy of taxanes owing to the action of β-elemene. In H460 and A549 cells, dose-dependent upregulation of p53 protein expression was observed in cultures treated with docetaxel alone and with docetaxel plus β-elemene, whereas no significant change in p53 expression was observed in any of the treatment groups in H23 cells. Fas revealed no alteration of expression with any of the treatments in this study. However, the combination treatments induced increased cytochrome c release from mitochondria, significant caspase-8 and -3 cleavage, and downregulation of Bcl-2 and Bcl-XL expression. These results suggest that, although p53 plays an important role in taxane-induced cell death, apoptosis induced by β-elemene or in combination with docetaxel thereof seems to be initiated through a p53- and Fas-independent pathway via mitochondria in our lung cancer cells. The suppression of specific 'survival' gene expression appears to be the key action leading to the synergistic effect of combination treatments with β-elemene and taxanes. Finally, the β-elemene-induced alteration of cell membrane permeability, which has potential to result in enhanced cellular uptake of taxanes, may also contribute to the synergistic interactions of the combination treatments.

Original languageEnglish (US)
Pages (from-to)241-252
Number of pages12
JournalInternational Journal of Oncology
Volume31
Issue number2
StatePublished - Aug 2007
Externally publishedYes

Fingerprint

Taxoids
docetaxel
Carcinoma
Lung
Pharmaceutical Preparations
Micronucleus Tests
Gene Expression
Lung Neoplasms
Mitochondria
In Vitro Techniques
elemene
Apoptosis
Cell Membrane Permeability
Null Lymphocytes
Caspase 8
Medicinal Plants
Paclitaxel
Cytochromes c
Caspase 3
Antineoplastic Agents

Keywords

  • β-elemene
  • Apoptosis
  • Combination index
  • Drug resistance
  • Lung cancer
  • Synergism
  • Taxane

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

In vitro combination characterization of the new anticancer plant drug β-elemene with taxanes against human lung carcinoma. / Zhao, Jinshun; Li, Qingdi Quentin; Zou, Baobo; Wang, Gangduo; Li, Xiping; Kim, Jee Eun; Cuff, Christopher F.; Huang, Lan; Reed, Eddie; Gardner, Kevin.

In: International Journal of Oncology, Vol. 31, No. 2, 08.2007, p. 241-252.

Research output: Contribution to journalArticle

Zhao, J, Li, QQ, Zou, B, Wang, G, Li, X, Kim, JE, Cuff, CF, Huang, L, Reed, E & Gardner, K 2007, 'In vitro combination characterization of the new anticancer plant drug β-elemene with taxanes against human lung carcinoma', International Journal of Oncology, vol. 31, no. 2, pp. 241-252.
Zhao, Jinshun ; Li, Qingdi Quentin ; Zou, Baobo ; Wang, Gangduo ; Li, Xiping ; Kim, Jee Eun ; Cuff, Christopher F. ; Huang, Lan ; Reed, Eddie ; Gardner, Kevin. / In vitro combination characterization of the new anticancer plant drug β-elemene with taxanes against human lung carcinoma. In: International Journal of Oncology. 2007 ; Vol. 31, No. 2. pp. 241-252.
@article{d85216436d474304b31540b62192c5ea,
title = "In vitro combination characterization of the new anticancer plant drug β-elemene with taxanes against human lung carcinoma",
abstract = "β-elemene has recently raised interest in P.R. China as a novel antitumor plant drug isolated from the Chinese medicinal herb Zedoary. To explore potentially useful combinations of β-elemene with taxanes in the clinic, we characterized the effects of β-elemene combined with taxanes in human lung cancer cells using a median effect analysis, micronucleus assay, apoptotic detection, and determination of gene expression in the signaling pathways of apoptosis. The synergistic analysis indicated that the interactions of β-elemene with paclitaxel or docetaxel ranged from slight synergism to synergism. Combinations of β-elemene with docetaxel induced much stronger synergistic interactions in p53 mutant H23 cells and p53 null H358 cells than in p53 wild-type H460 and A549 cells. Similar synergistic interactions were observed by micronucleus assay, apoptotic detection, and determination of apoptotic gene expression. Our findings indicate that the synergistic effects achieved with combinations of β-elemene and taxanes are related to the augmented cytotoxic efficacy of taxanes owing to the action of β-elemene. In H460 and A549 cells, dose-dependent upregulation of p53 protein expression was observed in cultures treated with docetaxel alone and with docetaxel plus β-elemene, whereas no significant change in p53 expression was observed in any of the treatment groups in H23 cells. Fas revealed no alteration of expression with any of the treatments in this study. However, the combination treatments induced increased cytochrome c release from mitochondria, significant caspase-8 and -3 cleavage, and downregulation of Bcl-2 and Bcl-XL expression. These results suggest that, although p53 plays an important role in taxane-induced cell death, apoptosis induced by β-elemene or in combination with docetaxel thereof seems to be initiated through a p53- and Fas-independent pathway via mitochondria in our lung cancer cells. The suppression of specific 'survival' gene expression appears to be the key action leading to the synergistic effect of combination treatments with β-elemene and taxanes. Finally, the β-elemene-induced alteration of cell membrane permeability, which has potential to result in enhanced cellular uptake of taxanes, may also contribute to the synergistic interactions of the combination treatments.",
keywords = "β-elemene, Apoptosis, Combination index, Drug resistance, Lung cancer, Synergism, Taxane",
author = "Jinshun Zhao and Li, {Qingdi Quentin} and Baobo Zou and Gangduo Wang and Xiping Li and Kim, {Jee Eun} and Cuff, {Christopher F.} and Lan Huang and Eddie Reed and Kevin Gardner",
year = "2007",
month = "8",
language = "English (US)",
volume = "31",
pages = "241--252",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "2",

}

TY - JOUR

T1 - In vitro combination characterization of the new anticancer plant drug β-elemene with taxanes against human lung carcinoma

AU - Zhao, Jinshun

AU - Li, Qingdi Quentin

AU - Zou, Baobo

AU - Wang, Gangduo

AU - Li, Xiping

AU - Kim, Jee Eun

AU - Cuff, Christopher F.

AU - Huang, Lan

AU - Reed, Eddie

AU - Gardner, Kevin

PY - 2007/8

Y1 - 2007/8

N2 - β-elemene has recently raised interest in P.R. China as a novel antitumor plant drug isolated from the Chinese medicinal herb Zedoary. To explore potentially useful combinations of β-elemene with taxanes in the clinic, we characterized the effects of β-elemene combined with taxanes in human lung cancer cells using a median effect analysis, micronucleus assay, apoptotic detection, and determination of gene expression in the signaling pathways of apoptosis. The synergistic analysis indicated that the interactions of β-elemene with paclitaxel or docetaxel ranged from slight synergism to synergism. Combinations of β-elemene with docetaxel induced much stronger synergistic interactions in p53 mutant H23 cells and p53 null H358 cells than in p53 wild-type H460 and A549 cells. Similar synergistic interactions were observed by micronucleus assay, apoptotic detection, and determination of apoptotic gene expression. Our findings indicate that the synergistic effects achieved with combinations of β-elemene and taxanes are related to the augmented cytotoxic efficacy of taxanes owing to the action of β-elemene. In H460 and A549 cells, dose-dependent upregulation of p53 protein expression was observed in cultures treated with docetaxel alone and with docetaxel plus β-elemene, whereas no significant change in p53 expression was observed in any of the treatment groups in H23 cells. Fas revealed no alteration of expression with any of the treatments in this study. However, the combination treatments induced increased cytochrome c release from mitochondria, significant caspase-8 and -3 cleavage, and downregulation of Bcl-2 and Bcl-XL expression. These results suggest that, although p53 plays an important role in taxane-induced cell death, apoptosis induced by β-elemene or in combination with docetaxel thereof seems to be initiated through a p53- and Fas-independent pathway via mitochondria in our lung cancer cells. The suppression of specific 'survival' gene expression appears to be the key action leading to the synergistic effect of combination treatments with β-elemene and taxanes. Finally, the β-elemene-induced alteration of cell membrane permeability, which has potential to result in enhanced cellular uptake of taxanes, may also contribute to the synergistic interactions of the combination treatments.

AB - β-elemene has recently raised interest in P.R. China as a novel antitumor plant drug isolated from the Chinese medicinal herb Zedoary. To explore potentially useful combinations of β-elemene with taxanes in the clinic, we characterized the effects of β-elemene combined with taxanes in human lung cancer cells using a median effect analysis, micronucleus assay, apoptotic detection, and determination of gene expression in the signaling pathways of apoptosis. The synergistic analysis indicated that the interactions of β-elemene with paclitaxel or docetaxel ranged from slight synergism to synergism. Combinations of β-elemene with docetaxel induced much stronger synergistic interactions in p53 mutant H23 cells and p53 null H358 cells than in p53 wild-type H460 and A549 cells. Similar synergistic interactions were observed by micronucleus assay, apoptotic detection, and determination of apoptotic gene expression. Our findings indicate that the synergistic effects achieved with combinations of β-elemene and taxanes are related to the augmented cytotoxic efficacy of taxanes owing to the action of β-elemene. In H460 and A549 cells, dose-dependent upregulation of p53 protein expression was observed in cultures treated with docetaxel alone and with docetaxel plus β-elemene, whereas no significant change in p53 expression was observed in any of the treatment groups in H23 cells. Fas revealed no alteration of expression with any of the treatments in this study. However, the combination treatments induced increased cytochrome c release from mitochondria, significant caspase-8 and -3 cleavage, and downregulation of Bcl-2 and Bcl-XL expression. These results suggest that, although p53 plays an important role in taxane-induced cell death, apoptosis induced by β-elemene or in combination with docetaxel thereof seems to be initiated through a p53- and Fas-independent pathway via mitochondria in our lung cancer cells. The suppression of specific 'survival' gene expression appears to be the key action leading to the synergistic effect of combination treatments with β-elemene and taxanes. Finally, the β-elemene-induced alteration of cell membrane permeability, which has potential to result in enhanced cellular uptake of taxanes, may also contribute to the synergistic interactions of the combination treatments.

KW - β-elemene

KW - Apoptosis

KW - Combination index

KW - Drug resistance

KW - Lung cancer

KW - Synergism

KW - Taxane

UR - http://www.scopus.com/inward/record.url?scp=35148900318&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35148900318&partnerID=8YFLogxK

M3 - Article

VL - 31

SP - 241

EP - 252

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 2

ER -